TY  - JOUR
AU  - U.S. Department of Health and Human Services Food and Drug Administration
AU  - Center for Drug Evaluation and Research (CDER)
AU  - Center for Biologics Evaluation and Research (CBER)
KW  - Safety Reporting Requirements for INDs and BA/BE Studies
PY  - 2012
TI  - Guidance for Industry and Investigators Safety Reporting Requirements for INDs and BA/BE Studies
UR  - http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htmorhttp://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/default.htm
ER  -
TY  - JOUR
AB  - Background More than 30 percent of patients with epilepsy have inadequate control of seizures with drug therapy, but why this happens and whether it can be predicted are unknown. We studied the res...
AU  - Atrick, P
AU  - Wan, K
AU  - Artin, M
AU  - Rodie, J B
DA  - 2009/8//
DO  - 10.1056/NEJM200002033420503
IS  - 5
PB  -  Massachusetts Medical Society 
PY  - 2009
SP  - 314
EP  - 319
TI  - Early Identification of Refractory Epilepsy
T2  - http://dx.doi.org/10.1056/NEJM200002033420503
UR  - https://www.nejm.org/doi/full/10.1056/nejm200002033420503
VL  - 342
ER  -